CUSIP: 68827R108
Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,297,422
-
Share change
-
-2,423,893
-
Total reported value
-
$41,643,377
-
Put/Call ratio
-
621%
-
Price per share
-
$5.71
-
Number of holders
-
77
-
Value change
-
-$25,575,265
-
Number of buys
-
36
-
Number of sells
-
33
Quarterly Holders Quick Answers
What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2016
-
Previous quarter:
Q4 2015
Recent filing periods for CUSIP 68827R108:
Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q1 2016
As of 31 Mar 2016,
OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,297,422 shares.
The largest 10 holders included
FMR LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BAKER BROS. ADVISORS LP, STATE STREET CORP, NORTHERN TRUST CORP, QS Investors, LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
77
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.